月之暗面将 Kimi 模型重心从编程转向科学研究
月之暗面认为编程领域的基准提升趋于平缓,正将 Kimi 系列模型转向生物、化学与制药研究。其国际总监 Giacomo Ficari 在里斯本 Web Summit 上表示,科学任务对模型智能的要求高于法律、金融与编程。DP Technology 已将 Kimi K3.1 Pro 集成进研究助手 BioMaster,在测试中用 90 分钟完成原本约需 4 小时的小鼠胰腺细胞基因分析并筛出 100 个候选基因,但完全自主的科学突破仍尚需时日。
报道正文
Moonshot AI pivots Kimi models from coding to science as benchmark gains flatten
[Manuel Uth](https://the-decoder.com/author/manuel-uth/) Nov 16, 2026 Because Moonshot AI sees diminishing returns in coding, the Beijing startup is redirecting its Kimi language models toward biology, chemistry, and pharma research. International director Giacomo Ficari said at the Web Summit in Lisbon that science demands smarter AI models than law, finance, or code.
Beijing startup DP Technology is integrating Kimi K3.1 Pro into its research assistant BioMaster. In one test, the AI analyzed gene data from 3,696 mouse pancreatic cells and flagged 100 candidate genes in 90 minutes instead of an estimated four hours of human work.
Fully independent breakthroughs are still a long way off. On TCSExam, a 100-problem theoretical CS benchmark, leading models produced verifiable proofs but couldn't crack any open conjectures alone. US rivals hit similar limits. Anthropic's Claude found an enzyme system in September, but mathematicians criticized OpenAI's claimed math and physics breakthroughs. The pharma industry isn't sold yet either. A June Citi survey of 50 US research leaders found 72 percent already using AI broadly, but only 24 percent expect it to noticeably improve drug development success rates.